Invention Application
US20080096860A1 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
有权
嘧啶磺酰胺衍生物作为趋化因子受体调节剂
- Patent Title: Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
- Patent Title (中): 嘧啶磺酰胺衍生物作为趋化因子受体调节剂
-
Application No.: US11574340Application Date: 2005-08-23
-
Publication No.: US20080096860A1Publication Date: 2008-04-24
- Inventor: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Neal Michael Smith , Jeffrey Paul Stonehouse , Cherylin Francis Preston
- Applicant: David Ranulf Cheshire , Rhona Jane Cox , Premji Meghani , Neal Michael Smith , Jeffrey Paul Stonehouse , Cherylin Francis Preston
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Priority: GB0419235.7 20040828; GB0502544.0 20050208
- International Application: PCT/GB05/03257 WO 20050823
- Main IPC: A61K31/513
- IPC: A61K31/513 ; C07D403/02
Abstract:
A compound of formula (1), or a pharmaceutically acceptable salt, solvate or in vivo hydrolysable ester thereof and pharmaceutical compositions comprising these, all for use in the treatment of chemokine mediated diseases and disorders.
Public/Granted literature
- US07838675B2 Pyrimidine sulphonamide derivatives as chemokine receptor modulators Public/Granted day:2010-11-23
Information query
IPC分类:
